Provided by Tiger Trade Technology Pte. Ltd.

Arcturus Therapeutics Ltd.

13.03
-0.1800-1.36%
Post-market: 13.030.00000.00%16:39 EDT
Volume:744.83K
Turnover:9.69M
Market Cap:370.22M
PE:-3.91
High:13.65
Open:13.33
Low:12.79
Close:13.21
52wk High:24.17
52wk Low:5.50
Shares:28.41M
Float Shares:26.28M
Volume Ratio:1.25
T/O Rate:2.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3289
EPS(LYR):-2.4021
ROE:-46.31%
ROA:-23.96%
PB:2.15
PE(LYR):-5.42

Loading ...

Arcturus Therapeutics Holdings Inc Expected to Post a Loss of 100 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Arcturus Therapeutics Updates Financial Calendar with Upcoming Q2 Results Release and Conference Call

Reuters
·
Jul 29

Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026

THOMSON REUTERS
·
Jul 29

Arcturus Therapeutics to Present at the Canaccord Genuity 46TH Annual Growth Conference

THOMSON REUTERS
·
Jul 21

Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Arcturus Therapeutics (ARCT)

TIPRANKS
·
Jul 15

U.S. Stocks on the Move-silicom, Blue Owl, Intel

Reuters
·
Jul 03

Analysts Offer Insights on Healthcare Companies: Faeth Therapeutics (FTH) and Arcturus Therapeutics (ARCT)

TIPRANKS
·
Jul 03

Arcturus, Thermo Fisher deal adds support to ARCT-032 exposure, says Roth

TIPRANKS
·
Jul 02

U.S. Stocks on the MOVE- Dollar Tree, Rivian, Arcturus

Reuters
·
Jul 02

Arcturus Rises on Thermo Fisher Collaboration for Rare Disease Drug

Reuters
·
Jul 02

Arcturus Therapeutics Partners with Thermo Fisher to Support Phase 3 Development of Cystic Fibrosis Therapy Arct-032

Reuters
·
Jul 02

Arcturus Therapeutics Holdings - Thermo Fisher to Receive Exclusive Commercial Manufacturing Rights for Arct-32

THOMSON REUTERS
·
Jul 02

Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance Arct-032 for Cystic Fibrosis

THOMSON REUTERS
·
Jul 02

Arcturus Therapeutics initiated with a Buy at Freedom Broker

TIPRANKS
·
Jul 02

Arcturus Therapeutics to Present at Jefferies Global Healthcare Conference

Reuters
·
May 27

ARCT Rating Reiterated at Hold as High-Risk ARCT-032 CF Program Awaits Binary Phase 2 Readout; $9 Price Target Maintained

TIPRANKS
·
May 13

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.
·
May 12

Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Arcturus Therapeutics Holdings Inc - Appoints Dennis Mulroy as CFO Effective May 1, 2026 - SEC Filing

THOMSON REUTERS
·
May 08

Arcturus Therapeutics CFO Dennis Mulroy files initial beneficial ownership statement

Reuters
·
May 08